Practical Application: Change Management, Adoption, GxP Compliance & Validation Requirements brings members together to discuss what happens once a pilot succeeds, when AI tools have to survive contact with validation, GxP compliance, and the people who actually have to use them day to day. Expect a candid, working conversation rather than a webinar, held […]
Join fellow Pistoia Alliance members for an engaging discussion of Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices by Dr. John LaMattina, former President of Pfizer Global Research and Development. The book explores one of the pharmaceutical industry’s most debated topics: how to balance innovation, patient access, and the economics of drug development. […]
Initiatives at Pistoia Alliance to improve pharmacovigilance Pharmacovigilance teams across the industry face the same problems: fragmented systems, duplicated effort, and no shared playbook for adopting AI safely and compliantly. The Pistoia Alliance has two complementary, pre-competitive initiatives to tackle these challenges together: Pharmacovigilance Systems & Processes Standards (PS²): building common business-process, system and interoperability […]
Your people are already using AI. They’re writing code with it, analyzing data with it, drafting regulatory documents with it – with or without your governance frameworks, your ontology standards, or your validation processes. The question isn’t whether to enable this; it’s whether you’re going to lead it or clean up after it. The […]
This end-of-summer seminar takes a longitudinal view of AI across the full drug development pipeline — from the earliest stages of target identification and validation through to clinical trial design and execution. Through in-depth case studies and expert presentations, participants will examine where AI is delivering genuine, measurable value and where significant challenges remain. […]
